A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss

Usher syndrome is an autosomal recessive condition characterized by sensorineural hearing loss, variable vestibular dysfunction, and visual impairment due to retinitis pigmentosa (RP). The seven proteins that have been identified for Usher syndrome type 1 (USH1) and type 2 (USH2) may interact in a large protein complex. In order to identify novel USH genes, we followed a candidate strategy, assuming that mutations in proteins interacting with this “USH network” may cause Usher syndrome as well. The DFNB31 gene encodes whirlin, a PDZ scaffold protein with expression in both hair cell stereocilia and retinal photoreceptor cells. Whirlin represents an excellent candidate for USH2 because it binds to Usherin (USH2A) and VLGR1b (USH2C). Genotyping of microsatellite markers specific for the DFNB31 gene locus on chromosome 9q32 was performed in a German USH2 family that had been excluded for all known USH loci. Patients showed common haplotypes. Sequence analysis of DFNB31 revealed compound heterozygosity for a nonsense mutation, p.Q103X, in exon 1, and a mutation in the splice donor site of exon 2, c.837+1G>A. DFNB31 mutations appear to be a rare cause of Usher syndrome, since no mutations were identified in an additional 96 USH2 patients. While mutations in the C-terminal half of whirlin have previously been reported in non-syndromic deafness (DFNB31), both alterations identified in our USH2 family affect the long protein isoform. We propose that mutations causing Usher syndrome are probably restricted to exons 1–6 that are specific for the long isoform and probably crucial for retinal function. We describe a novel genetic subtype for Usher syndrome, which we named USH2D and which is caused by mutations in whirlin. Moreover, this is the first case of USH2 that is allelic to non-syndromic deafness.

[1]  A R Fielder,et al.  Usher syndrome in the city of Birmingham—prevalence and clinical classification , 1997, The British journal of ophthalmology.

[2]  T. Rosenberg,et al.  The prevalence of Usher syndrome and other retinal dystrophy‐hearing impairment associations , 1997, Clinical genetics.

[3]  K. Steel,et al.  Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. , 1998, American journal of human genetics.

[4]  The usher syndromes. , 1999, American journal of medical genetics.

[5]  A. Mansour,et al.  A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C , 2000, Nature Genetics.

[6]  Sue Malcolm,et al.  A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene , 2000, Nature Genetics.

[7]  D. Landau,et al.  A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. , 2001, American journal of human genetics.

[8]  M. Lathrop,et al.  DFNB31, a recessive form of sensorineural hearing loss, maps to chromosome 9q32-34 , 2002, European Journal of Human Genetics.

[9]  Klaus Rohrschneider,et al.  Prevalence and geographical distribution of Usher syndrome in Germany , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[10]  Karen B Avraham,et al.  A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome. , 2003, The New England journal of medicine.

[11]  S. Riazuddin,et al.  The molecular genetics of Usher syndrome , 2003, Clinical genetics.

[12]  Steve D. M. Brown,et al.  Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31 , 2003, Nature Genetics.

[13]  R. Desnick,et al.  Genetic homogeneity and phenotypic variability among Ashkenazi Jews with Usher syndrome type III , 2003, Journal of medical genetics.

[14]  M. Marmor,et al.  Standard for clinical electroretinography (2004 update) , 2004, Documenta Ophthalmologica.

[15]  Eberhart Zrenner,et al.  Standard for clinical electroretinography , 1989, Documenta Ophthalmologica.

[16]  C. Möller,et al.  Audiological findings in Usher syndrome types IIa and II (non-IIa) , 2004, International journal of audiology.

[17]  C. Cremers,et al.  USH2A Mutation analysis in 70 Dutch families with Usher syndrome type II , 2004, Human mutation.

[18]  J. Sellers,et al.  Myosin-XVa is required for tip localization of whirlin and differential elongation of hair-cell stereocilia , 2005, Nature Cell Biology.

[19]  Aziz El-Amraoui,et al.  Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. , 2005, Human molecular genetics.

[20]  P. Legrain,et al.  Myosin XVa and whirlin, two deafness gene products required for hair bundle growth, are located at the stereocilia tips and interact directly. , 2005, Human molecular genetics.

[21]  Steve D. M. Brown,et al.  Mutant analysis reveals whirlin as a dynamic organizer in the growing hair cell stereocilium. , 2005, Human molecular genetics.

[22]  D. Weil,et al.  Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non‐syndromic recessive hearing loss , 2005, Human mutation.

[23]  C. Cremers,et al.  The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1. , 2006, Human molecular genetics.

[24]  R. Roepman,et al.  Usher syndrome: molecular links of pathogenesis, proteins and pathways. , 2006, Human molecular genetics.

[25]  C. Cremers,et al.  The DFNB 31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH 2 A and VLGR 1 , 2006 .